Novel subtype of nasopharyngeal carcinoma and Epstein-Barr virus–associated immune suppression discovered

Focused chemists in lab coats and safety goggles making experiments.

Researchers from the Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong (HKUMed) discovered a novel subtype of Epstein-Barr virus (EBV)–positive nasopharyngeal carcinoma (NPC) and EBV-associated immunosuppression in the tumor-microenvironment (TME).

Poor gut health may drive multiple sclerosis—better diet may ease it

Previous article

Management strategy makes a difference in C-section rates, study finds

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations